4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-25-011335
See remarks sold 45,464 shares at an average $4.50 ($204,753)
- See remarks acquired 139,141 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rahmer Peter See remarks | 2025-01-28 | Sale | −1,673 | $4.63 | $7,746 | 307,081 | D: show line 1 in the form |
| Rahmer Peter See remarks | 2025-01-28 | Grant or award | +139,141 | 446,222 | D: show line 2 in the form | ||
| Rahmer Peter See remarks | 2025-01-29 | Sale | −26,541 | $4.55 | $120,762 | 419,681 | D: show line 3 in the form |
| Rahmer Peter See remarks | 2025-01-30 | Sale | −17,250 | $4.42 | $76,245 | 402,431 | D: show line 4 in the form |
| Open-market sales · 45,464 sh · avg $4.50 · $204,753 | |||||||
Loading xslF345X05/ownership.xml…